![FDA just approved the first drug to prevent migraines. Here's the story of its discovery—and its limitations | Science | AAAS FDA just approved the first drug to prevent migraines. Here's the story of its discovery—and its limitations | Science | AAAS](https://www.science.org/do/10.1126/science.aae0189/abs/migrainelead1280x720.jpg)
FDA just approved the first drug to prevent migraines. Here's the story of its discovery—and its limitations | Science | AAAS
![Teva Pharmaceutical | $TEVA Stock | Shares Rally After Winning FDA Approval for Migraine Therapy - Warrior Trading News Teva Pharmaceutical | $TEVA Stock | Shares Rally After Winning FDA Approval for Migraine Therapy - Warrior Trading News](https://marketexclusive.com/wp-content/uploads/2017/02/Teva-Pharmaceutical-Industries-Ltd.jpg)
Teva Pharmaceutical | $TEVA Stock | Shares Rally After Winning FDA Approval for Migraine Therapy - Warrior Trading News
![Teva's AJOVY Receives FDA Approval for the Treatment of Migraine in Adults with Monthly and Quarterly Teva's AJOVY Receives FDA Approval for the Treatment of Migraine in Adults with Monthly and Quarterly](https://pharmashots.com/public/images/20211115200220_ogImage_47.jpg)
Teva's AJOVY Receives FDA Approval for the Treatment of Migraine in Adults with Monthly and Quarterly
![FDA Approves Teva's Ajovy Injection for the Prevention and Treatment of Migraine in Adults | Specialty Pharma Journal FDA Approves Teva's Ajovy Injection for the Prevention and Treatment of Migraine in Adults | Specialty Pharma Journal](https://www.spjnews.com/wp-content/uploads/2015/04/Teva.jpg)
FDA Approves Teva's Ajovy Injection for the Prevention and Treatment of Migraine in Adults | Specialty Pharma Journal
![AbbVie pressures Biohaven in migraine prevention with FDA approval for its CGRP blockbuster-to-be Qulipta | FiercePharma AbbVie pressures Biohaven in migraine prevention with FDA approval for its CGRP blockbuster-to-be Qulipta | FiercePharma](https://qtxasset.com/fiercepharma/1632922452/Qulipta.jpg?VersionId=IgLO33WeIF31seP37wjQ7qrLctTmOAbr)